An immigrant entrepreneur, Andrea Pais cofounded Novel Microdevices by figuring it out as she went along — and learning where to find support.

MALVERN, Pa. - Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company trading near its 52-week low of $2.99, has announced the initiation of a Phase 3 trial for its Alzheimer's disease ...

Synthetic biologists have developed a prototype for an innovative biosensor that can detect rare earth elements and be modified for a range of other applications.

Bioengineering Professor Kiana Aran is one of three inaugural winners of the Sony Women in Technology Award with Nature. She ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology has been developed.

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.

Develop research skills in biotechnology and scientific knowledge applicable to a range of careers, including working as a consultant, in business development, as a research and development manager, ...

Soon after starting a new biotechnology company, David Li realized he needed to rethink his strategy. Li had been conducting the competitive research biotech entrepreneurs typically undertake before ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

On Wednesday the U.S. Department of Commerce announced it would implement new export controls on certain biotechnology equipment, citing national security concerns relating to artificial ...